Skip to content

Evaluation of the effect of clinical pharmacist intervention based on drug-related problems: a randomized controlled trial

Evaluation of the effect of clinical pharmacist intervention based on drug-related problems: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095602
Enrollment
Unknown
Registered
2025-01-09
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Intervention group:Clinical Pharmacist-led Pharmaceutical Services
Control group:Usual care

Sponsors

Zhejiang Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Hospitalized patients; 2. Hospitalization time greater than 3 days; 3. Adult patients with age >=18 years and <=100 years (due to the difference between juvenile patients and adult patients, only adult patients over 18 years old were included for drug treatment management studies); 4. The patient or close relatives have informed consent, and are willing to communicate with clinical pharmacists and accept medication life education.

Exclusion criteria

Exclusion criteria: 1. Those who do not meet the inclusion criteria; 2. Patients who need emergency treatment in the acute stage of the disease; 3. Have any serious or life-threatening diseases (heart, lung, liver, kidney failure, hematologic diseases, malignant tumors, etc.); 4. Patients with mental disorders, hearing impairments, intellectual disabilities, aphasia, etc., resulting in inability to communicate or inability to comply with the study protocol; 5. Any other reasons that the investigator believes may affect the efficacy and safety evaluation of this study and are not suitable for participating in this clinical trial (including but not limited to those who are judged by the investigator to live far away and cannot be followed up as scheduled).

Design outcomes

Primary

MeasureTime frame
Number of drug-related problems;

Secondary

MeasureTime frame
Medication Adherence;Patients' knowledge;Patient satisfaction in the experimental group;

Countries

China

Contacts

Public ContactJieping Yan

Zhejiang Provincial People's Hospital

pinkieyan@126.com+86 13588461492

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026